Clinical Trial Update: MRD-positive AML Clinical Study [NA]

View source ↗

Summary

A China-based clinical trial is recruiting adults with MRD-positive acute myeloid leukemia, sponsored by the Institute of Hematology & Blood Diseases Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: AML, Adult | NA | Status: RECRUITING